Pfizer Amoy Diagnostics, Pierre Fabre Collaborate to Develop CDx in China The companion diagnostic kits will support marketing authorization applications for Pfizer's Braftovi and Mektovi. EU Project Screen4Care Will Apply Sequencing, AI to Screen Newborns for Rare Diseases Premium The project involves numerous biopharmaceutical firms, including Pfizer, Roche, Takeda Pharmaceuticals, Sanofi, Novartis, ProQR Therapeutics, Lysogene, and Novo Nordisk. Codex DNA Bets on Enzymatic Building Block Method for Gene Synthesis Premium The short oligo ligation assembly (SOLA) enzymatic DNA synthesis method uses a library of DNA building blocks to make oligos that are then assembled into genes. Sema4 to Embrace Co-CEO Model After $623M Acquisition of GeneDx Premium The purchase of GeneDx from Opko Health will help Sema4 accelerate its push into whole-exome sequencing and grow in rare disease diagnostics. Sema4 to Acquire GeneDx for $623M While GeneDx parent Opko Health is essentially exiting the MDx business, it will pick up a "significant" stake in Sema4. Nov 30, 2021 Exact Sciences, Pfizer End Cologuard Copromotion Agreement Jul 28, 2021 AbbVie, Biogen, Pfizer Join With Broad Institute on Genebass Exome Variant Project Premium Mar 2, 2021 Strata Oncology, Pfizer Partner to Explore New Biomarker Indications for FDA-Approved Drugs Dec 9, 2020 Nonprofit Friends of Cancer Research Launches Public-Private HRD Harmonization Project Dec 7, 2020 UK Biobank Collaborating With Biopharmas to Profile Plasma Proteome of 53K Subjects Oct 30, 2020 Opko Health Q3 Revenues Up 87 Percent Oct 29, 2020 Roche EGFR Mutation Test Approved by FDA as Companion Diagnostic for NSCLC Nov 13, 2019 Pfizer Inks Deal for Access to Centogene Rare Disease Data Sep 23, 2019 Global Survey Reveals Suboptimal Molecular Testing Access in Lung Cancer Despite Broad Guidelines Premium Jul 23, 2019 Pfizer, Syapse Ink Real-World Precision Oncology Collaboration Jun 6, 2019 TAPUR Study Investigators Report First Positive Findings, Pursuing Tissue-Agnostic Cohorts Premium Jun 4, 2019 At ASCO, Real-World Data Shows Potential to Improve Precision Oncology Premium Apr 30, 2019 Exact Sciences Q1 Revenues Up 79 Percent Jan 16, 2019 Qiagen EGFR Assay Approved in Japan as CDx to Pfizer NSCLC Drug Oct 30, 2018 Exact Sciences Q3 Revenues Up 63 Percent Oct 30, 2018 Precision Oncology Highlights From ESMO 2018 Oct 16, 2018 FDA Approves Myriad Genetics BRCA CDx With Pfizer's Metastatic Breast Cancer Drug Oct 12, 2018 AmoyDx Lung Cancer CDx Approved in South Korea Oct 10, 2018 Myriad Upgraded to Overweight by Piper Jaffray; Signs Lab Service Deal with Pfizer Aug 22, 2018 Exact Sciences, Pfizer to Comarket Cologuard Load More Breaking News Single-Nucleus Chromatin Accessibility Profiling in Coronary Artery Disease Points to Mechanisms ALL Genomes Marked by High DNA Methylation Levels Cepheid Gets CE Mark for Updated Rapid COVID MDx Test Mainz Biomed, Dante Labs Partner to Commercialize ColoAlert in Europe, UAE CellCarta Acquires Rights to Targeted Protein Assays from Fred Hutch Spinout Precision Assays Genetic Analysis, Omnigene Medical Technologies Ink Distribution, Tech Transfer Deal The Scan Monkeypox Case Found in US The New York Times says that a case of monkeypox has now been reported in the US. Effects on Fetal Screening Wired writes that changes to US abortion laws could affect screening for fatal congenital conditions. 'Pharma Bro' Out of Prison The Wall Street Journal reports that Martin Shkreli has been released from prison to a halfway house. Nature Papers Present Cultivate Oat Genome, Benchmarking of Spatial and Single-Cell Transcriptomic Integration Methods In Nature this week: reference genome of the cultivated oat, and more.